Candriam S.C.A. Trims Holdings in Cigna Group $CI

Candriam S.C.A. reduced its position in shares of Cigna Group (NYSE:CI) by 41.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 47,149 shares of the health services provider’s stock after selling 33,035 shares during the period. Candriam S.C.A.’s holdings in Cigna Group were worth $12,577,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Banco Bilbao Vizcaya Argentaria S.A. grew its stake in Cigna Group by 13.5% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after acquiring an additional 4,066 shares during the period. Distillate Capital Partners LLC lifted its stake in shares of Cigna Group by 19.1% during the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock worth $31,338,000 after purchasing an additional 17,442 shares during the period. Cooperman Leon G lifted its stake in shares of Cigna Group by 53.3% during the 3rd quarter. Cooperman Leon G now owns 325,000 shares of the health services provider’s stock worth $93,681,000 after purchasing an additional 113,000 shares during the period. apricus wealth LLC boosted its holdings in shares of Cigna Group by 715.9% during the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after purchasing an additional 8,340 shares during the last quarter. Finally, Danske Bank A S acquired a new stake in shares of Cigna Group during the third quarter worth $51,862,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of CI stock opened at $293.36 on Monday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market cap of $77.60 billion, a PE ratio of 12.44, a P/E/G ratio of 1.13 and a beta of 0.29. The company’s fifty day simple moving average is $285.67 and its 200-day simple moving average is $279.76. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the prior year, the firm earned $6.74 EPS. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts anticipate that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CI has been the subject of several analyst reports. UBS Group upped their target price on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Barclays lowered Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $310.00 to $304.00 in a research note on Tuesday, May 26th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Guggenheim increased their price objective on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Royal Bank Of Canada raised their target price on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.